Less invasive systems for ablation of fat pads
CA 2550174 C · Owner: Biosense Webster, Inc. · Inventors: Schwartz, Yitzhack
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Epicardial fat pad ablation is conducted using a catheter inserted through the chest wall using ultrasound ablation, or using a catheter fitted with a directional ultrasound transducer and capable of being aligned with the epicardium. The epicardial fat pad locations are determined using noninvasive imaging methods or using electrical maps. These locations are then displayed on maps or images of the heart and thus targeted for minimally invasive or non invasive therapy. The methods of the present invention are less invasive than conventional methods of ablation and permit flexible access to substantially any point on the epicardium.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2006 and granted August 29, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 14, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.